RTRX Message Board Post 9752570 | Travere Therapeutics
home / stock / rtrx / rtrx message board
pauldgreen
(investorshub)
Posted on: Aug/22/2019 14:26:34
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150689204
As of last public report, more than 4
News, Short Squeeze, Breakout and More Instantly...
-
SAN DIEGO, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Travere Therapeutics (NASDAQ: TVTX) today announced completion of patient enrollment in the Phase 3 DUPLEX Study. The pivotal DUPLEX Study is evaluating the safety and efficacy of sparsentan for the treatment of focal segmental glomerulosclerosis...
-
New name reflects dedication to patient- inspired mission of identifying, developing and delivering life-changing rare disease therapies Company’s s hares to t rade u nder n ew t icker s ymbol TVTX on Novem...
-
SAN DIEGO, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced the completion of its previously announced acquisition of Orphan Technologies Limited, a privately held, clinical-stage biopharmaceutical company focused on the development of product candidate OT-58...